BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23624734)

  • 21. Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases.
    Hong HS; Jung J; Park SH; Kim HJ; Hwang SW; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    Korean J Intern Med; 2022 Jan; 37(1):73-84. PubMed ID: 34482682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination programs for children aged up to 18 years in Europe, 2020.
    Effraimidou E; Cassimos DC; Medic S; Topalidou M; Theodoridou M; Maltezou HC
    J Child Health Care; 2023 Sep; 27(3):336-350. PubMed ID: 34844456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.
    Black AP; Vilivong K; Nouanthong P; Souvannaso C; Hübschen JM; Muller CP
    PLoS One; 2015; 10(4):e0123647. PubMed ID: 25874696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.
    Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Giannotta M; Girardin G; Kiudelis G; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Martinez-Ares D; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Arebi N; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    J Crohns Colitis; 2014 Jul; 8(7):607-16. PubMed ID: 24315795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Have your young pediatric patients been immunized properly?
    Waldman HB
    ASDC J Dent Child; 1998; 65(2):107-10. PubMed ID: 9617450
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunization against infectious disease.
    Olshin IJ
    Compr Ther; 1984 Jun; 10(6):13-9. PubMed ID: 6734129
    [No Abstract]   [Full Text] [Related]  

  • 31. Can we better protect patients with inflammatory bowel disease against infections - patient attitude and personal immunization knowledge.
    Waszczuk K; Waszczuk E; Szenborn L
    Acta Gastroenterol Belg; 2018; 81(2):257-261. PubMed ID: 30024696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Ruiz-Cuesta P; González-Alayón C; Jurado-García J; Iglesias-Flores EM; Barranco-Quintana JL; García-García L; Salgueiro-Rodríguez IM; Benitez-Cantero JM; García-Sánchez V
    Gastroenterol Hepatol; 2016; 39(6):385-92. PubMed ID: 26601992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
    Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
    Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
    Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported history of vaccination and disease and immunity against hepatitis A, hepatitis B, tetanus, diphtheria and varicella among Spanish military recruits.
    Arteaga A; Desviat PV; Jaqueti J; Santos J; de Miguel AG; Garcia RJ
    Hum Vaccin; 2010 Feb; 6(2):198-201. PubMed ID: 20009540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease.
    Pittet LF; Verolet CM; Michetti P; Gaillard E; Girardin M; Juillerat P; Mottet C; Maillard MH; Siegrist CA; Posfay-Barbe KM;
    Digestion; 2021; 102(6):956-964. PubMed ID: 33971650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
    Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
    J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.